维普中文期刊产品整合服务
88篇 您的检索式:作者名="Stallmach"
    题名 作者 年代 出处 被引量
1Risk factors and outcome of bacterial infections in cirrhosis显示文摘Viable and non-viable pathological bacterial translocation promote a self-perpetuating circle of dysfunctional immune activation and systemic inflammation facilitating infections and organ failure in advanced cirrhosis.Bacterial infections and sepsis are now recognized as a distinct stage in the natural progression of chronic liver disease as they accelerate organ failure and contribute to the high mortality observed in decompensated cirrhosis.The increasing knowledge of structural,immunological and hemodynamic pathophysiology in advanced cirrhosis has not yet translated into significantly improved outcomes of bacterial infections over the last decades.Therefore,early identification of patients at the highest risk for developing infections and infectionrelated complications is required to tailor the currently available measures of surveillance,prophylaxis and therapy to the patients in need in order to improve the detrimental outcome of bacterial infections in cirrhosis.Tony Bruns Henning W Zimmermann Andreas Stallmach 2014World Journal of Gastroenterology2014,20,10:24
2Dual-sugar tests of small intestinal permeability are poor predictors of bacterial infections and mortality in cirrhosis: a prospective study显示文摘AIM: To prospectively analyze the impact of increased intestinal permeability(IP) on mortality and the occurrence of infections in patients with cirrhosis.METHODS: IP was quantified using the lactulose/mannitol(L/M) test in 46 hospitalized patients with cirrhosis(25 Child-Pugh A/B, 21 Child-Pugh C) and in 16 healthy controls. Markers of inflammation [LPSbinding protein, Interleukin-6(IL-6)] and enterocyte death [intestinal fatty-acid binding protein(I-FABP)] were determined in serum using enzyme-linked immunosorbent assays. Patients were followed for one year and assessed for survival, liver transplantation, the necessity of hospitalization and the occurrence of bacterial infections. The primary endpoint of the study was defined as differences in survival between patients with pathological and without pathological lactulose/mannitol test.RESULTS: Thirty-nine(85%) patients with cirrhosis had a pathologically increased IP index(L/M ratio > 0.07) compared to 4(25%) healthy controls(P < 0.0001). The IP index correlated with the ChildPugh score(r = 0.484, P = 0.001) and with serum IL-6(r = 0.342, P = 0.02). Within one year, nineteen(41%) patients developed a total of 33 episodes of hospitalization with bacterial or fungal infections. Although patients who developed spontaneous bacterial peritonitis(SBP)(n = 7) had a higher IP index than patients who did not(0.27 vs 0.14, P = 0.018), the baseline IP index did not predict time to infection, infection-free survival or overall survival, neither when assessed as linear variable, as tertiles, nor dichotomized using an established cut-off. In contrast, model for end-stage liver disease score, Child-Pugh score, the presence of ascites, serum IL-6 and I-FABP were univariate predictors of infection-free survival.CONCLUSION: Although increased IP is a frequent phenomenon in advanced cirrhosis and may predispose to SBP, it failed to predict infection-free and overall survival in this prospective cohort study.Anika Vogt Philipp A Reuken Sven Stengel Andreas Stallmach Tony Bruns 2016World Journal of Gastroenterology2016,22,11:8
3Parameters of a severe disease course in ulcerative colitis显示文摘AIM:To detect high risk patients with a progressive disease course of ulcerative colitis(UC) requiring immunosuppressive therapy(IT).METHODS:A retrospective,multicenter analysis of 262 UC patients from eight German tertiary inflammatory bowel disease centres was performed.Patients were divided into two groups depending on the patients need to initiate immunosuppressive therapy in the disease course.A comparison between the two groups was made with regard to demographics,clinical and laboratory parameters obtained within three months after UC diagnosis and the response to first medical therapy.Using this data,a prognostic model was established to predict the individual patients probability of requiring an immunosuppressive therapy.RESULTS:In 104(39.7%) out of 262 patients,UC therapy required an immunosuppressive treatment.Patients in this group were significantly younger at time of diagnosis(HR = 0.981 ± 0.014 per year,P = 0.009),and required significantly more often a hospitalisation(HR = 2.5 ± 1.0,P < 0.001) and a systemic corticosteroid therapy at disease onset(HR = 2.4 ± 0.8,P < 0.001),respectively.Response to steroid treatment was significantly different between the two groups of patients(HR = 5.2 ± 3.9 to 50.8 ± 35.6 compared to no steroids,P = 0.016 to P < 0.001).Furthermore,in the IT group an extended disease(HR = 3.5 ± 2.4 to 6.1 ± 4.0 compared to proctitis,P = 0.007 to P = 0.001),anemia(HR = 2.2 ± 0.8,P < 0.001),thrombocytosis(HR = 1.9 ± 1.8,P = 0.009),elevated C-reactive protein(CRP)(HR = 2.1 ± 0.9,P < 0.001),and extraintestinal manifestations in the course of disease(HR = 2.6 ± 1.1,P = 0.004) were observed.Six simple clinical items were used to establish a prognostic model to predict the individual risk requiring an IT.This probability ranges from less than 2% up to 100% after 5 years.Using this,the necessity of an immunosuppressive therapy can be predicted in 60% of patients.Our model can determine the need for an immunosuppressive drug therapy or if a 'watch and wait' approach is reasonable already early in the treatment course of UC.CONCLUSION:Using six simple clinical parameters,we can estimate the patients individual risk of developing a progressive disease course.Andreas Stallmach Luisa Nickel Thomas Lehmann Bernd Bokemeyer Martin Bürger Dietrich Hüppe Wolfgang Kruis Susanna Nikolaus Jan C Preiss Andreas Sturm Niels Teich Carsten Schmidt 2014World Journal of Gastroenterology2014,20,35:2
4Aber-rant positioning of trophoblast and lymphocytes in the feto-maternal interface with pre-eclampsia显示文摘STALLMACH T HEBISCH G ORBAN P 1999Virchows Arch1999,434,3:1
5Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn's disease显示文摘 Giese T Schmidt C 2004Int J Colorectal Dis2004,19,4:1
6Malignant trans-formation in inflammatory bowel disease-surveillanceguide显示文摘Stallmach A Bielecki C Schmidt C 2009Dig Dis2009,27,4:1
7Constitutively overexpressed erythropoietin reduces infarct size in a mouse model of permanent coronary artery ligation显示文摘Camici G G Stallmach T Hermann M 2007Methods Enzymol2007,435,:1
8Abortion in mice with excessive erythrocytosis is due to impaired arteriogenesis of the U- terine Arcade显示文摘Gassmann M Manini A Stallmach T 2008Biol Reprod2008,78,6:1
9Cystic nephroma: a rare benign renal tumor显示文摘P. Sacher U. V. Willi F. Niggli T. Stallmach 1998Pediatric Surgery International (-)1998,,2:1
10Carboxylates and sulfates of polysaccharides for controlled internal water release during cement hydration显示文摘Karen Friedemann Frank Stallmach Jorg Karger 2009Cement Concrete Compos2009,31,4:1
11Drug delivery strategies for targeted treatment of inflammatory bowel disease显示文摘C. Lautenschl?ger C. Schmidt K. Lange A. Stallmach 2015Z Gastroenterol2015,,:1
12Abortion in mice with excessive erythrocytosis is due to impaired arteriogenesis of the Uterine Arcade显示文摘Gassmann M Manini A Stallmach T 2008Biol Reprod2008,78,6:1
13Low toxic neoadjuvant cisplatin, 5-fluorouracil and folinic acid in locally advanced gastric cancer yields high R-0 resection rate显示文摘Markus Menges Carsten Schmidt Werner Lindemann Karsten Ridwelski Werner Pueschel Bernhard Jüngling Gernot Feifel Martin Schilling Andreas Stallmach Martin Zeitz 2003Journal of Cancer Research and Clinical Oncology2003,,7:1
14A boy with congenital analbu-minemia and steroid-sensitive idiopathic nephrotic syndrome: an experiment of nature 显示文摘Neuhaus TJ Stallmach T Genewein A 2008Eur Pediatr2008,167,9:1
15Acute appendicitis in neonates:complication or morbus sui generic?显示文摘 Stallmach T Sacher P 1998Pediatr Surg Int1998,14,12:1
16Image cytometric DNA analysis of adrenocortical neoplasms as a prognostic parameter:a clinico-pathologic study of 13 patients显示文摘LU X STALLMACH T GEBBERS JO 1996Anal Cell Pathol1996,12,1:1
17Altered glycosylation of inte- grin adhesion molecules in colorectal cancer cells and decreased adhe- sion to the extracellular matrix 显示文摘von Lampe B Stallmach A Riecken EO 1993Gut1993,34,6:1
18Contrast-enhanced endoscopic ultrasound in discrimination between benign and malignant mediastinal and abdominal lymph nodes显示文摘Michael Hocke Markus Menges Theodor Topalidis Christoph F. Dietrich Andreas Stallmach 2008Journal of Cancer Research and Clinical Oncology2008,,4:1
19Ueo pouch-anal anastomosis显示文摘STALLMACH A SCHMIDT C 2007Internist (Berl)2007,48,6:1
20Role of infections in the manifestation on reactivation of inflammatory bowel disease显示文摘Stallmach A Carstan S 2002Inflammatory bowel disease2002,8,3:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费